ARTHUR J. HIGGINS

Corporate Board Profile

Tech Score: 0/100

ECOLAB INC.

Filing Date	Source Excerpt
2020-03-20	Arthur J. Higgins, 64 years old, President and Chief Executive Officer of Assertio Therapeutics, Inc. Member of the Compensation and Safety, Health and Environment Committees. Director compensation total $280,621.
2021-03-19	Consultant to Blackstone Healthcare Partners L.L.C. of The Blackstone Group L.P., an investment company sourcing, analyzing and overseeing investments in the area of pharmaceuticals and medical products. Director of Ecolab since 2010. Member of the Compensation and Safety, Health and Environment Committees.
2022-03-18	Mr. Higgins has extensive leadership experience in the global healthcare market.
2023-03-17	Arthur J. Higgins, Independent Director: Yes, Age: 67, Board Member since: 2010, Board Committees: Compensation & Human Capital Management, Safety, Health & Environment, Director Compensation Table: Total $300,512.
2024-03-15	Mr. Higgins brings to the Board extensive leadership experience and enterprise risk management in the healthcare and life sciences industries. Through leadership positions with large life sciences developers and manufacturers in both the United States and Europe, Mr. Higgins has gained deep knowledge of the life sciences and healthcare businesses and the strategies for developing and marketing products in these highly regulated industries. This background allows him to provide valuable insight to Ecolab’s life sciences business, including quality and operating risk management, and expertise related to complex chemical manufacturing environments. In addition, his global perspective from years of operating global businesses and his background in working with high growth companies informs Ecolab’s ambitions for sustainable growth.

ENZON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2003-10-28	Arthur J. Higgins, has served as the Company's President, Chief Executive Officer and a director of the Company since May 31, 2001, and Chairman of the Board since December 3, 2001. Mr. Higgins graduated from Strathclyde University, Scotland and holds a B.S. degree in biochemistry.
2004-10-28	ARTHUR J. HIGGINS, has served as director of the Company since May 31, 2001, and served as Chairman of the Board from December 2001 to September 2004. Since May 2004, Mr. Higgins has served as Chairman of the Executive Committee of Bayer Healthcare. From May 2001 to May 2004 Mr. Higgins was the Company's President and Chief Executive Officer. Prior to joining the Company, Mr. Higgins had been with Abbott Laboratories for 14 years and most recently served as Senior Vice President of Pharmaceutical Operations since 1998. He also held various other positions at Abbott Laboratories, including Vice President of Pacific, Asia and Africa Operations and Vice President of International Business Development. Previously, Mr. Higgins worked for Bristol-Myers and Sandoz in the U.K. Mr. Higgins graduated from Strathclyde University, Scotland and holds a B.S. degree in biochemistry.

Filing Date

Source Excerpt

2003-10-28

Arthur J. Higgins, has served as the Company's President, Chief Executive Officer and a director of the Company since May 31, 2001, and Chairman of the Board since December 3, 2001. Mr. Higgins graduated from Strathclyde University, Scotland and holds a B.S. degree in biochemistry.

2004-10-28

ARTHUR J. HIGGINS, has served as director of the Company since May 31, 2001, and served as Chairman of the Board from December 2001 to September 2004. Since May 2004, Mr. Higgins has served as Chairman of the Executive Committee of Bayer Healthcare. From May 2001 to May 2004 Mr. Higgins was the Company's President and Chief Executive Officer. Prior to joining the Company, Mr. Higgins had been with Abbott Laboratories for 14 years and most recently served as Senior Vice President of Pharmaceutical Operations since 1998. He also held various other positions at Abbott Laboratories, including Vice President of Pacific, Asia and Africa Operations and Vice President of International Business Development. Previously, Mr. Higgins worked for Bristol-Myers and Sandoz in the U.K. Mr. Higgins graduated from Strathclyde University, Scotland and holds a B.S. degree in biochemistry.

Data sourced from SEC filings. Last updated: 2025-06-30